Long-term DNA methylation changes mediate heterologous cytokine responses after BCG vaccination
- PMID: 40629459
- PMCID: PMC12239379
- DOI: 10.1186/s13059-025-03611-9
Long-term DNA methylation changes mediate heterologous cytokine responses after BCG vaccination
Abstract
Background: Epigenetic reprogramming shapes immune memory in both innate (trained immunity) and adaptive immune cells following Bacillus Calmette-Guérin (BCG) vaccination. However, the role of dynamic DNA methylation changes in post-vaccination immune responses remains unclear.
Results: We established a cohort of 284 healthy Dutch individuals, profiling genome-wide DNA methylation and cytokine responses to ex vivo stimulation at baseline, 14 days, and 90 days post-BCG vaccination. We identified distinct patterns of DNA methylation alternations in the short- and long-term following BCG vaccination. Moreover, we established that baseline DNA methylation profiles exert influence on the change in interferon-γ (IFN-γ) production upon heterologous (Staphylococcus aureus) stimulation before and after BCG vaccination. Specifically, we identified the regulation of kisspeptin as a novel pathway implicated in the modulation of IFN-γ production, and this finding has been substantiated through experimental validation. We also observed associations between BCG-induced DNA methylation changes and increased IFN-γ and interleukin-1 β (IL-1β) production upon S. aureus stimulation. Interestingly, by integrating with genetic, epigenetic, and cytokine response data from the same individuals, mediation analysis demonstrated that most of the identified DNA methylation changes played a mediating role between genetic variants and cytokine responses; for example, the changes of cg21375332 near SLC12 A3 gene mediated the regulation of genetic variants on IFN-γ changes after BCG vaccination. Sex-specific effects were observed in DNA methylation and cytokine responses, highlighting the importance of considering sex in immune studies.
Conclusions: These findings provide deeper insights into immune response mechanisms, crucial for developing effective epigenetic-based medical interventions for personalized medicine.
Keywords: BCG vaccination; Cytokines response; DNA methylation; Systems biology; Trained immunity.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: The 300BCG study was approved by the Arnhem-Nijmegen Medical Ethical Committee (NL58553.091.16). All participants have given written informed consent. Competing interests: MGN is the scientific founder of TTxD, Lemba, Salvina, and Biotrip. LABJ is the scientific founder of TTxD, Lemba, and Salvina. None of these start-ups have objectives that intersect with this study. The other authors declare that they have no competing interests.
Figures
References
-
- Netea MG, Quintin J, van der Meer JWM. Trained immunity: a memory for innate host defense. Cell Host Microbe. 2011;9:355–61. - PubMed
-
- Arts RJW, Moorlag SJCFM, Novakovic B, Li Y, Wang SY, Oosting M, et al. BCG vaccination protects against experimental viral infection in humans through the induction of cytokines associated with trained immunity. Cell Host Microbe. 2018;23:89-100.e5. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
